Oncopharmpod
Tremelimumab & Teclistamab
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:23:26
- Mas informaciones
Informações:
Sinopsis
New Drug Approvals! -Tremelimumab, the 2nd CTLA-4 inhibitor, finally gets approved. -Teclistamab, an excited BCMA-CD3 T-cell engager for multiple myeloma.
